Library - Page 4 - Scientific articles and publications about the drug Mexidol®.

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The effect of Mexidol on physical performance and lactate in the blood of rats in conditions of light desingronosis

Authors

GOSTYUKHINA A.A., ZAITSEV K.V.ZAMOSCHINA T.A., Svetlik M.V.

Place of publication:

Journal of Neurology and Psychiatry, 11, 2018

The influence of Mexidol on the expression of the NRF2 transcription factor in the cortex of the large hemispheres of the brain with experimental ischemia

Authors:
YAKUSHEVA E.N., MYLNIKOV P.Yu., CHERNYKH I.V., SHCHULKIN A.V.

FGBOU in the Ryazan State Medical University named after Acad. I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

Place of publication:
JOURNAL OF NEUROLOGY AND PSYCHIATRY, 5, 2018

The influence of Mexidol on the expression of the factor induced by HIF-1α hypoxia in the cortex of the large hemispheres of the brain of rats with ischemia

Authors:
YAKUSHEVA E.N., MYLNIKOV P.Yu., CHERNYKH I.V., SHCHULKIN A.V.

FGBOU in the Ryazan State Medical University named after Acad. I.P. Pavlova ", Ryazan, Russia

Geronto -informational analysis of the properties of the Mexidol molecule

Authors:
GROMOVA O.A. ^1.2*, TORSHIN I.Yu.^2*, FEDOTOVA L.E. ^1*

^1*Federal State Budgetary Educational Institution of Higher Education "Ivanovo State Medical Academy", Ivanovo;
^2*Federal Research Center "Informatics and Control" of the Russian Academy of Sciences, Moscow

Comparative chemoreactic analysis of Mexidol

Authors:
TORSHIN I.YU. ^1*, GROMOVA O.A. ^2*, SARDARYAN I.S. ^3*, FEDOTOVA L.E.^3*

^1*Moscow Institute of Physics and Technology, Dolgoprudny, Russia;
^2*Ivanovo State Medical Academy of the Ministry of Health of the Russian Federation, Ivanovo, Russia;
^3*Saint Petersburg State Pediatric University of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia

The distribution of Mexidol in the structures of the brain, its cellular elements and subcellular fractions

Authors:
SHCHULKIN A.V., YAKUSHEVA E.N., CHERNYKH I.V.

Ryazan State Medical University named after Academician I.P. Pavlova

Mexidol and hepatitis: the results in the experiment and prospects in the clinic

Author:
FARASCHUK N.F.

GOU VPO Smolensk State Medical Academy

Features and mechanism of the neuroprotective action of Mexidol with hemorrhagic stroke in the experiment

Author:
V.A. KRAINEVA

GU Nii Pharmacology named after V.V. Zakusov RAMS, Moscow

Mexidol: modern aspects of pharmacokinetics and pharmacodynamics

Authors:

Schulkin A.V.

FSBEN in the Ryazan State Medical University of the Russian Federation, Ryazan

Mexidol: a spectrum of pharmacological effects

Author:
VORONINA T.A.

Nii pharmacology named after V.V. Zakusov RAMS, Moscow

Mexidol: the main neuropsychotropic effects and the mechanism of action

Author:
T.A. VORONINA

GU "Nii Pharmacology named after V.V. Zakusov "RAMS, Moscow

Pharmacology of antioxidants based on 3-oxypyridine

Authors:
NOVIKOV V.E., KOVALEVA L.A., LOSENKOVA S.O., KLIMKINA E.I.

Smolensk State Medical Academy

Treatment of alcohol cancellation syndrome

Author:
SIVOLAP Yu.P.

FGBAOU VO "First Moscow State Medical University named after THEM. Sechenov "Ministry of Health of Russia (Sechenov University), Moscow, Russia

The possibility of using Mexidol in the complex therapy of mental disorders

Authors:
SHAMREY V.K., KURASOV E.S., NECHIPORENKO V.V., KOLCHEV A.I., TSYGAN N.V.

FGBVOU in the "Military Medical Academy named after CM. Kirov ”, St. Petersburg, Russia

The dynamics of electroenzelographic and psychophysiological indicators in acute poisoning by neurotoxicants at the rehabilitation stage against the background of various treatment methods

Authors:

BADALYAN A.V., BEREZINA I.Yu., GOLDFARB Yu.S., SUMSKY L.I.

Place of publication:

Journal of Neurology and Psychiatry, 2, 2017

The influence of Mexidol in combination with therapy with antidepressants on sleep disturbance with panic disorder in young people

Authors:
KURASOV E.S. , REMIZEVICH R.S.

Military Medical Academy. CM. Kirova, St. Petersburg

« 1 2 3 4 5 6 … 14 »